Akeso Inc

Common Name

Akeso

Country

China (Mainland)

Sector

Healthcare

Industry

Biotechnology

Employees

3,529

Ticker

9926

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.akesobio.com

Description

Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating ... Show more

Financial Statements of Akeso

Below are the financial statements of Akeso, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of CNY	2024	2023
Non-current assets	—	—
Property, plant and equipment	3,230.69^a	2,823.98^a
Right-of-use assets	319.51^a	338.04^a
Intangible assets	11.8^a	6.42^a
Financial assets at fair value through profit or loss	16.31^a	12.04^a
Long-term equity investment	398.5^a	293.44^a
Other non-current assets	86.57^a	30.4^a
Total non-current assets	4,063.38^a	3,504.32^a
Current assets	—	—
Inventories	706.53^a	391.87^a
Trade receivables	524.91^a	295.56^a
Prepayments, other receivables and other assets	116.29^a	94.92^a
Financial assets at fair value through profit or loss	425.79^a	852.43^a
Cash and bank balances	6,918.07^a	4,041.99^a
Total current assets	8,691.59^a	5,676.77^a
Current liabilities	—	—
Trade payables	425.19^a	354.83^a
Other payables and accruals	715.14^a	443.58^a
Interest-bearing bank and other borrowings	535.46^a	390.51^a
Lease liabilities	9.67^a	14.51^a
Tax payable	1.17^a	1.15^a
Total current liabilities	1,686.63^a	1,204.58^a
Net current assets	7,004.96^a	4,472.18^a
Total assets less current liabilities	11,068.34^a	7,976.51^a
Non-current liabilities	—	—
Interest-bearing bank and other borrowings	3,406.13^a	2,577.27^a
Contract liabilities	617.63^a	631.65^a
Lease liabilities	0.67^a	8.61^a
Deferred income	290.25^a	240.03^a
Deferred tax liabilities	0.17^a	0.17^a
Total non-current liabilities	4,314.86^a	3,457.73^a
Net assets	6,753.47^a	4,518.78^a
Equity	—	—
Share capital	0.06^a	0.06^a
Shares held for restricted share unit schemes	-48.6^a	-63.57^a
Reserves	6,862.49^a	4,755.85^a
Equity attributable to owners of the parent	6,813.95^a	4,692.34^a
Non-controlling interests	-60.48^a	-173.56^a
Total equity	6,753.47^a	4,518.78^a

Verified Sources Behind Akeso’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Akeso’s data sources below and access millions more through our Disclosure Search.

a. Akeso's Annual Report 2024

Trace every data point back to Akeso’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Akeso Inc

Financial Statements of Akeso

Verified Sources Behind Akeso’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

WuXi Biologics (Cayman) Inc

Pharmaron Beijing Co Ltd

Zai Lab Ltd

Genscript Biotech Corp

CSPC Pharmaceutical Group Ltd

Hansoh Pharmaceutical Group Company Ltd